First-in-Class Inhibitors of Oncogenic CHD1L With Preclinical Activity Against Colorectal Cancer

Since the discovery of CHD1L in 2008 it has emerged as an oncogene implicated in the pathology and poor prognosis of a variety of cancers, including gastrointestinal cancers. However, a mechanistic understanding of CHD1L as a driver of colorectal cancer (CRC) has been limited. Until now, there have...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Mol Cancer Ther
Κύριοι συγγραφείς: Abbott, Joshua M., Zhou, Qiong, Esquer, Hector, Pike, Laura, Broneske, Travis P., Rinaldetti, Sébastien, Abraham, Adedoyin D., Ramirez, Dominique A., Lunghofer, Paul J., Pitts, Todd M., Regan, Daniel P., Tan, Aik Choon, Gustafson, Daniel L., Messersmith, Wells A., LaBarbera, Daniel V.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: 2020
Θέματα:
Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7665848/
https://ncbi.nlm.nih.gov/pubmed/32499299
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-20-0106
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια